However, treatment of db/db mice with bioactive peptides nephrilin or anephril significantly reduced IRS2, p-IRS1-Ser307, serum/glucocorticoid-regulated kinase 1 and phospho-PKC-α/β which, when elevated, are associated with diabetic nephropathy [42]. Here, IRS2 is linked to diabetic kidney disease.